Japanese firm Takeda have gained shareholders’ approval for the $62 billion acquisition of the Irish headquartered company Shire Plc.
The deal is set to see Asia’s largest pharma firm become a major global player, as the acquisition is set to propel the Osaka-based company into the top 10 biggest pharmaceutical firms worldwide.
The approval comes after a long and convoluted process through which shareholders clashed with Takeda executives over the specifics of the momentous acquisition.
